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The human T cell leukemia virus type I (HTLV-I) is an oncogenic retrovirus that is etiologically linked to the genesis of adult T cell
leukemia (ATL) as well as HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Emerging evidence suggests that the
pathogenicity of HTLV-I involves deregulated activation of immune cells, especially T lymphocytes, although the underlying mechanism
remains unclear. In this study, we demonstrate that HTLV-I Tax induces the aberrant expression of CD40, a member of the tumor necrosis
factor receptor (TNFR) family that plays an important role in lymphocyte activation and differentiation. In a panel of HTLV-I-transformed T
cell lines analyzed, CD40 expression was highly elevated compared to HTLV-I-negative T cells. Using Tax mutants and a genetically
manipulated T cell system, we demonstrated that Tax-induced CD40 expression required the NF-nB signaling pathway. In addition, ligation
of CD40 on T cells with recombinant CD40L elicited NF-nB activation, suggesting that the CD40 pathway is intact and may participate in a
positive regulatory loop in T cells. CD40 ligation strongly synergized with Tax to activate NF-nB, suggesting that CD40 signals may
costimulate Tax-mediated NF-nB activation, particularly when Tax is expressed at low levels. Collectively, these results indicate that CD40 is
a novel Tax-regulated gene, and the regulation of CD40 by Tax may play a role in cellular activation and HTLV-I-induced disease
pathogenesis.
D 2004 Elsevier Inc. All rights reserved.
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Human T cell leukemia virus type I (HTLV-I) is the
etiologic agent of an aggressive malignancy known as adult
T cell leukemia (ATL) and a demyelinating neurological
disorder referred to as HTLV-I associated myelopathy/
tropical spastic paraparesis (HAM/TSP) (Grant et al.,0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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ogy, Sylvester Comprehensive Cancer Center, The University of Miami
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E-mail address: eharhaj@med.miami.edu (E.W. Harhaj).2002; Miyoshi et al., 1981; Osame et al., 1986; Poiesz et
al., 1980). The pX region of the HTLV-I genome encodes
several regulatory and accessory viral proteins, including
the trans-activating protein Tax that is essential for viral
gene expression and replication (Franklin and Nyborg,
1995; Yao and Wigdahl, 2000). Tax is negatively regulated
by an additional viral protein, encoded in open reading
frame II (ORF-II) of the pX region, known as p30II
(Albrecht and Lairmore, 2002). p30II acts as a post-
transcriptional negative regulator of viral replication by
retaining doubly spliced mRNA encoding Tax and Rex in
the nucleus, thus resulting in a specific reduction of both
Tax and Rex protein (Nicot et al., 2004).05) 145–158
E.W. Harhaj et al. / Virology 333 (2005) 145–158146Tax modulates the expression of cellular genes that
impact cellular activation, survival, growth, and trans-
formation (Ballard et al., 1988; de La Fuente et al., 2000;
Ng et al., 2001; Pise-Masison et al., 2002; Yoshida, 2001).
The effect of Tax on cellular gene expression is primarily
mediated by the activation of cellular signaling cascades and
transcription factors. One well-defined target transcription
factor of Tax is NF-nB/Rel, a family of enhancer binding
proteins that play a central role in cell growth and survival
(Barkett and Gilmore, 1999; Jeang, 2001; Sun and Ballard,
1999). The mammalian NF-nB is composed of five
subunits, RelA (p65), p50, c-Rel, p52, and RelB, which
form various homo- and hetero-dimeric protein complexes
(Rothwarf and Karin, 1999). The NF-nB proteins all contain
a Rel homology domain (RHD) that has been shown to
confer DNA binding, nuclear localization, and dimerization
properties. NF-nB is held inactive in the cytosol by a family
of inhibitory proteins known as InBs that mask the nuclear
localization signals of NF-nB (Beg et al., 1992). NF-nB
agonists, such as the cytokines TNF-a and IL-1, activate
NF-nB by inducing the activity of an InB kinase (IKK)
which is composed of two catalytic subunits, IKKa and
IKKh, and a regulatory component, IKKg (Zandi et al.,
1997). The activated IKK phosphorylates InBs, triggering
their proteolysis through the ubiquitin/proteasome pathway,
which facilitates nuclear import of NF-nB and activation of
target genes (Karin, 1999). The IKK regulatory subunit
IKKg is essential for activation of IKK and NF-nB by
cytokines and Tax (Harhaj et al., 2000; Makris et al., 2000;
Yamaoka et al., 1998). Tax constitutively activates the IKK
complex in HTLV-I-infected T cells by a mechanism
involving physical interaction with IKKg (Chu et al.,
1999; Harhaj and Sun, 1999; Jin et al., 1999).
CD40 is a member of the tumor necrosis factor receptor
(TNFR) family and is expressed on a wide variety of cell
types including B cells, dendritic cells (DCs), macrophages,
endothelial cells, and neurons (van Kooten and Banchereau,
2000). The ligand for CD40 (CD40L) is primarily expressed
on activated T lymphocytes and interacts with CD40 to
orchestrate humoral and cellular immune responses.
Engagement of CD40 on B cells leads to cell proliferation,
differentiation, and immunoglobulin (Ig) isotype class
switching (Foy et al., 1996). Ligation of CD40 on DCs
acts as a potent maturation signal by mediating increased
expression of MHC and costimulatory molecules (Caux et
al., 1994; Cella et al., 1996; Schuurhuis et al., 2000). CD40
and CD40L null mice exhibit profound defects in Ig isotype
class switching, germinal center formation, B cell activation,
and antigen-specific T cell priming (Grewal et al., 1995;
Kawabe et al., 1994; Xu et al., 1994). In addition, patients
with hyper-IgM syndrome harbor mutations in either
CD40L or CD40 that result in impaired interactions of
CD40 and CD40L and lead to defective T cell responses and
a lack of Ig isotype class switching (Aruffo et al., 1993;
Bhushan and Covey, 2001). Signaling through CD40
activates a variety of signaling cascades including the NF-nB pathway (Berberich et al., 1994; Francis et al., 1995;
O’Sullivan and Thomas, 2002), and CD40-mediated NF-nB
activation is critical for the induction of primary response
genes required for B cell activation (Dadgostar et al., 2002).
HTLV-I infection deregulates the expression of several
members of the TNF and TNFR families such as OX40,
OX40L, CD30, TNF-a, and LT-h (Harhaj et al., 1999;
Higashimura et al., 1996; Pankow et al., 2000; Paul et al.,
1990; Pise-Masison et al., 2002). It is likely that altered
expression of these proteins enhances both cell survival
and costimulation of immune responses. Interestingly,
HTLV-I modulates the expression of CD40L in infected
T cells in a disease-specific manner. HTLV-I-infected
patients with ATL lack expression of CD40L on CD4+ T
cells, but those with HAM/TSP exhibit prolonged CD40L
expression on CD4+ T cells in vitro (Makino et al., 2001).
Therefore, sustained expression of CD40L coincides with
hyper-stimulated immune responses in HAM/TSP, and lack
of CD40L is associated with immunosuppression that is a
characteristic feature of ATL patients. The receptor for
CD40L, CD40, is expressed on the cell surface of HTLV-I-
infected cells (Dezzutti et al., 1995), although the role of
Tax in CD40 expression and also the functional effects of
CD40 expression within T cells are unknown. In this
report, we demonstrate that HTLV-I and Tax modulate the
expression of several TNF/TNFR genes, including CD40
in T lymphocytes. CD40 is normally not expressed in T
cells, although its expression is increased in T cells
associated with specific pathogenic states such as diabetes
(Wagner et al., 2002). Tax upregulates CD40 expression by
activating the NF-nB pathway. CD40 expression on T cells
may participate in a positive regulatory loop by activation
of transcription factors such as NF-nB and may be
involved in HTLV-I-mediated immune dysfunction and
disease pathogenesis.Results
Deregulation of TNF/TNFR genes by HTLV-I Tax
Previous studies by our laboratory and others have
demonstrated that HTLV-I and Tax deregulate the expres-
sion of a wide array of cellular genes involved in activation,
growth, and apoptosis (de La Fuente et al., 2000; Harhaj et
al., 1999; Ng et al., 2001; Pise-Masison et al., 2002). In
order to more fully define genes of the TNF/TNFR
superfamilies that are deregulated by Tax, we performed
gene array analysis with a commercially available kit
containing membranes spotted with cDNAs representing
23 different TNF/TNFR members as well as two house-
keeping genes (GEArray Original Series Human TNF and
TNFR Superfamily Gene Array; SuperArray). For a
complete listing of all of the genes on the array, see
www.superarray.com. Sup-T1 T cells were infected with
recombinant retroviruses using supernatants from 293 cells
Table 1
Deregulation of TNF/TNFR genes by Tax
Gene name Gene array position Fold change
CD40 2C, 2D 7.7m
LT-a 5C, 5D 5x
CD40L 2E, 2F 3.6m
Fas 3A, 3B 3.5m
OX40L 4E, 4F 1.8m
OX40 4C, 4D 1.5m
CD30 1E, 1F 1.6m
CD27 1A, 1B 1.5m
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vector (pCLXSN) or Tax (pCLXSN-Tax). Total RNA from
infected cells was converted into cDNA probes and
hybridized to membranes for gene array analysis. Tax
mRNA was readily detectable by RT-PCR in SUP-T1 cells
infected with Tax but not the empty vector (data not shown).
Tax deregulated the expression of several genes within the
TNF and TNFR superfamilies (Fig. 1 and Table 1). In
agreement with previous studies, Tax induced the expres-
sion of both OX40 (Higashimura et al., 1996) and OX40L
(Ohtani et al., 1998; Pise-Masison et al., 2002) (Table 1).
Tax also mediated the induction of CD40, CD40L, Fas,
CD27, and CD30. Interestingly, Tax induction of CD40
mRNA was strongest of all the genes on the array. It has
been previously demonstrated that HTLV-I infection may
regulate the expression of CD30 (Harhaj et al., 1999),
CD40L (Makino et al., 2001), and CD40 (Dezzutti et al.,
1995). Only one gene, lymphotoxin-a, was down-regulated
by Tax (Table 1). Importantly, the levels of the house-
keeping genes h-actin (3G, 4G) and GAPDH (5G, 6G, 7G,
8E, 8F and 8G) were unaltered by the expression of Tax
(Fig. 1). The remainder of our studies was focused on
characterization of CD40 as a Tax-regulated gene and
potential functional outcomes of CD40 ligation on T cells.
CD40 expression is upregulated by Tax in HTLV-I-infected
T cell lines
Although the expression of cell surface CD40 on
HTLV-I-infected T cell lines has been previously noted
(Dezzutti et al., 1995), it is unclear how and why CD40 is
induced by HTLV-I. To verify that CD40 was indeed
overexpressed in HTLV-I-infected T cell lines, we examinedFig. 1. Deregulation of TNF/TNFR genes by HTLV-I Tax. Gene array analysis was
SUP-T1 cells. SUP-T1 cells were infected with recombinant retroviruses from 293
encoding Tax (pCLXSN-Tax). Five days after infection, total RNA was isolated a
and TNFR Superfamily Gene Array Kit. Individual genes were spotted in duplica
cDNA from SUP-T1 cells infected with an empty vector (control), and the gene arra
expressing retroviruses (Tax). The boxed region represents duplicate spots of the C
the two arrays. Genes found to be deregulated by Tax at least 1.5-fold are listedmRNA levels of CD40 in a panel of HTLV-I-infected T cell
lines and uninfected negative controls. There was a striking
correlation between HTLV-I infection and CD40 mRNA
expression. CD40 mRNA was readily detected in the four
HTLV-I-infected T cell lines examined (Fig. 2A, lanes 3–6),
but not in the HTLV-I-negative control cell lines, Jurkat and
SUP-T1 (lanes 1 and 2). As expected, only the HTLV-I-
infected T cell lines expressed Tax, and the levels of the
housekeeping gene GAPDH were comparable between all
cell lines examined (Fig. 2A). The cell surface expression
levels of CD40 were next examined in each of the cell lines
by flow cytometry. As expected, all of the HTLV-I-infected
cell lines expressed CD40 on the cell surface (Fig. 2B), while
the uninfected Jurkat and SUP-T1 cell lines did not express
any CD40 on the cell surface (Fig. 2B). These results
indicate that HTLV-I infection induces the expression of
CD40 on T cells.
The HTLV-I Tax gene product is the primary viral
trans-activator protein which modulates both viral and
cellular gene expression. Our gene array study suggested
that Tax was responsible for the induction of CD40 in T
cells. To confirm the gene array results, retroviral vectorsperformed with mRNA from Tax-infected SUP-T1 cells or control-infected
cells infected with either an empty vector (pCLXSN) or a retroviral vector
nd subjected to gene array analysis using the GEArray Original Series TNF
te on the membrane. The gene array membrane on the left was probed with
y on the right was probed with cDNA from SUP-T1 cells infected with Tax-
D40 gene. Individual spots were quantitated for direct comparison between
in Table 1.
Fig. 2. Expression of CD40 in HTLV-I-infected T cell lines. (A) RT-PCR analysis of CD40 (top panel), Tax (middle panel), and GAPDH (lower panel)
expression in Jurkat and SUP-T1 control T cell lines (lanes 1 and 2), and C8166, MT-2, HUT-102, and SLB-1 HTLV-I-infected T cell lines (lanes 3–6). (B)
Flow cytometry of Jurkat and SUP-T1 control T cell lines and C8166, MT-2, SLB-1, and HUT-102 HTLV-I-infected T cell lines. Cells were either stained with
an anti-CD40-PE antibody or an isotype control-PE antibody and subjected to flow cytometry with FACScan 2000. Data analysis was performed with
CellQuest software.
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2001), Tax M22, or Tax M47 were used to infect either
Jurkat or SUP-T1 cells. Tax M22 and M47 represent point
mutations that allow segregation of Tax function; M22 has
a specific defect in NF-nB activation whereas M47 has a
specific defect in the CREB activation pathway (Smith and
Greene, 1990). The expression of Tax was determined to
be less cytotoxic to SUP-T1 cells compared to Jurkat cells
(data not shown), therefore experiments were primarily
performed with SUP-T1 cells. SUP-T1 cells infected with
supernatant from 293 cells transfected with Tax, Tax M22,
and Tax M47 retroviral vectors expressed similar levels of
Tax mRNA (Fig. 3A, lanes 2–4). Interestingly, only Tax
and Tax M47 were able to induce CD40 mRNA (Fig. 3A,
lanes 1–4), suggesting that the NF-nB pathway was
required. The levels of GAPDH were similar in all of
the indicated samples (Fig. 3A).
Tax is a potent activator of the NF-nB transcription factor
and activates the expression of numerous cellular genes via
the NF-nB pathway. To further investigate the role of NF-
nB in Tax-mediated CD40 gene expression, we used a
Jurkat mutant cell line (JM4.5.2) defective in NF-nB
signaling due to the lack of IKKg (Harhaj et al., 2000).Reintroduction of IKKg, but not GFP, in these cells was
able to fully revert the mutant phenotype (Harhaj et al.,
2000; Rivera-Walsh et al., 2000). We performed retroviral
infections of Tax in JM4.5.2 cells expressing either GFP or
IKKg. Expression of Tax in IKKg but not GFP-expressing
mutant cells was able to induce CD40 expression (Fig. 3B,
lanes 5 and 6). Collectively, these results indicate that CD40
is a Tax-regulated gene whose expression requires NF-nB
activation.
Activation of the CD40 promoter by Tax
Since Tax is a potent trans-activating protein, it is likely
that Tax induces CD40 expression at the transcriptional
level. Previous studies have identified four putative NF-nB
sites in the upstream region of the CD40 promoter that play
a role in response to lipopolysaccharide (LPS) and
interferon-gamma (IFN-g) in B cells and macrophages,
respectively (Nguyen and Benveniste, 2002; Tone et al.,
2002). An additional study indicated that the promoter-
proximal NF-nB site was essential for CD40 promoter
activation by overexpressed NF-nB in COS-7 cells (Hinz et
al., 2001). In addition to NF-nB sites, there are also three
Fig. 3. HTLV-I Tax is sufficient to induce CD40 expression and requires NF-nB. (A) SUP-T1 cells were infected with retroviral vectors encoding either empty
vector (pCL), Tax, Tax M22, or Tax M47. Total RNAwas isolated using Trizol reagent from cells 1 week post-infection and converted to cDNA. Gene products
representing Tax, CD40, and GAPDH were amplified by RT-PCR with cDNA from infected SUP-T1 cells. (B) JM4.5.2 cells (Jurkat cells deficient in IKKg)
stably transfected with either GFP (JM4.5.2-GFP) or IKKg (JM4.5.2-IKKg) were infected with retroviral vectors encoding Tax. Total RNAwas isolated using
Trizol reagent from cells 1 week post-infection and converted to cDNA. Gene products representing Tax, CD40, and GAPDH were amplified by RT-PCR with
cDNA from uninfected and infected cells.
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STAT factors (Nguyen and Benveniste, 2000) (Fig. 4A).
There are also 2 Sp1 sites proximal to the start site (Fig.
4A). To determine if Tax was able to activate the CD40
promoter, 747 nucleotides of the CD40 upstream region
were cloned into pGL3 to direct the expression of a firefly
luciferase reporter gene. Notably, all four NF-nB sites are
located within this region (Fig. 4A). Expression of Tax, but
not the empty vector, activated the CD40 promoter in Jurkat
T cells (Fig. 4B). In addition, Tax M22, defective in NF-nB
activation, was unable to effectively activate the CD40
promoter but was still proficient at activating the HTLV-I
LTR (Fig. 4B). Tax M47, which can activate NF-nB, but not
CREB/ATF, was able to activate the CD40 promoter at
levels similar to wild type (Fig. 4B). These results suggest
that Tax activates the CD40 promoter in an NF-nB-
dependent manner.
To localize the precise regions of the CD40 promoter
necessary for Tax-mediated activation, several deletion
mutants were constructed (Fig. 4C). Of note, pGL3-
CD40(544) lacks the most distal NF-nB site (NF-nB1).
pGL3-CD40(427), (327), and (198) lack the three
most distal NF-nB sites (NF-nB1, NF-nB2, and NF-nB3),
and pGL3-CD40(56) lacks all four NF-nB sites. Tax
activated all of the CD40 reporter deletion constructs with
similar efficiency with the exception of 56, suggesting that
the Tax-responsive element in the CD40 promoter resided
between 198 and 56 (Fig. 4C). Importantly, the proximal
NF-nB site (NF-nB4) resides within this region. To
determine whether NF-nB4 was essential for Tax-mediated
activation of the CD40 promoter, site-directed mutagenesis
was performed in the context of pGL3-CD40 (747) to
abrogate the NF-nB site. The mutation was targeted to the 3V
end of the NF-nB site in order to leave the adjacent GAS
element intact. When NF-nB4 was mutated, Tax-mediated
activation of the CD40 promoter was significantly reduced(Fig. 4D). Interestingly, the basal levels of the CD40
promoter were increased when NF-nB4 was mutated (Fig.
4D), indicating that NF-nB may repress the basal levels of
the CD40 promoter. Regardless, Tax requires the proximal
NF-nB element (NF-nB4) for optimal activation of the
CD40 promoter. Notably, this site was found to be essential
for CD40 promoter activation by overexpressed NF-nB in
COS-7 cells (Hinz et al., 2001).
Activation of T cells by the phorbol ester PMA and the
calcium ionophore ionomycin leads to activation of IKK
and NF-nB (Harhaj et al., 2000). Due to the importance of
NF-nB in Tax-mediated regulation of CD40 expression, the
effect of combined treatment with PMA and ionomycin on
the activation of the CD40 promoter was examined.
Surprisingly, PMA and ionomycin stimulation was unable
to activate the CD40 promoter despite the presence of four
putative NF-nB elements (Fig. 4E). However, combined
stimulation with these agents was a potent activator of the
control NF-nB reporter (Fig. 4E). Stimulation of primary
human peripheral blood T cells or Jurkat T cells with PMA
and ionomycin similarly failed to induce CD40 mRNA or
protein expression (data not shown). These results suggested
that NF-nB was required, but not sufficient, for Tax-induced
CD40 gene expression. It was also possible that Tax may
have activated NF-nB subunits that were distinct from those
induced by mitogens.
HTLV-I and Tax elicit NF-jB subunit binding to the
proximal CD40 NF-jB element
The next objective was to determine if HTLV-I infection
elicited NF-nB binding to the proximal NF-nB element
(NF-nB4) in the CD40 promoter. EMSA was performed
with double-stranded oligonucleotides representing the NF-
nB4 element. Protein complexes bound to the NF-nB4 site
were detected with nuclear extracts derived from all of the
Fig. 4. HTLV-I Tax activates the CD40 promoter via NF-nB. (A) A schematic representation of the CD40 promoter (747) and select transcription factor
binding sites. (B) Jurkat cells (1  106) were transfected with either 0.25 Ag pGL3-CD40(747), 0.2 Ag HTLV-I LTR luciferase, or 0.2 Ag NF-nB-TATA
luciferase together with 0.25 Ag pCMV4-Tax, Tax-M22, Tax-M47, or empty vector using FuGENE 6. Cells were harvested 48 h post-transfection and
luciferase activity was measured with a luminometer. The results are represented as the fold induction by Tax or Tax mutants relative to the vector alone. The
error bars represent the standard error of the mean (SEM) of five independent transfections. (C) Jurkat cells (1  106) were transfected with 0.25 Ag of the
indicated CD40 luciferase reporter constructs and either 0.25 Ag of empty vector or pCMV4-Tax. The fold induction of luciferase activity by Tax was
calculated for each construct. The error bars represent the SEM of seven independent transfections. (D) Jurkat cells (1  106) were transfected with either 0.25
Ag of pGL3-CD40(747) or pGL3-CD40(747) with the proximal NF-nB site mutated (NF-nB4 mut) together with either 0.25 Ag of empty vector or
pCMV4-Tax. The fold induction of luciferase activity was calculated as described above and is shown in the left panel. The basal level of pGL3-CD40(747)
NF-nB4 mut relative to pGL3-CD40(747) is shown in the right panel. The error bars represent the SEM of five independent transfections. (E) Jurkat cells
(1  106) were transfected with 0.25 Ag of either pGL3-CD40(747) or NF-nB-TATA luciferase together with either 0.25 Ag of an empty vector or pCMV4-
Tax. Cells were either left untreated or treated with PMA (10 ng/ml) and ionomycin (2 AM) for 8 h prior to harvest. The fold induction of Tax activity was
calculated relative to the empty vector. The fold induction of PMA and ionomycin stimulation was calculated relative to untreated cells transfected with empty
vector. The error bars represent the SEM of three independent transfections.
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Fig. 5. HTLV-I infection is associated with binding of NF-nB factors to the NF-nB4 site in the CD40 promoter. (A) Nuclear extracts (4 Ag) from control Jurkat
and SUP-T1 cells, and HTLV-I-infected C8166, MT-2, HUT-102, and SLB-1, were incubated with a [32P]-labeled double-stranded DNA probe representing the
CD40 NF-nB4 site in EMSA reactions (left panel). Nuclear extracts from Jurkat cells either untreated (lane 7) or treated with PMA (10 ng/ml) and ionomycin
(2 AM) for 30 min (lane 8) or 6 h (lane 9) were subjected to EMSAwith the CD40 NF-nB4 probe. (B) Nuclear extracts from either C8166 (lanes 1–4) or MT-2
cells (lanes 5–8) were subjected to competition analysis with a 50-fold molar excess of unlabeled double-stranded oligonucleotides representing the CD40 NF-
nB4 site (lanes 2 and 6), a mutant CD40 NF-nB4 site (lanes 3 and 7), or a consensus NF-nB site from the IL-2Ra promoter (lanes 4 and 8). The indicated
unlabeled oligonucleotides were incubated with nuclear extracts for 20 min on ice prior to binding reactions. (C) Nuclear extracts from either C8166 (lanes 1–
6), MT-2 (lanes 7–12) or Jurkat cells treated with PMA and ionomycin for 6 h (lanes 13–18) were subjected to supershift assays with either no antibody (lanes
1, 7, and 13), anti-RelA (p65; lanes 2, 8, and 14), anti-p50 (lanes 3, 9, and 15), anti-c-Rel (lanes 4, 10, and 16), anti-p52 (lanes 5, 11, and 17), or anti-control
rabbit Ig (lanes 6, 12, and 18). The indicated antibodies were incubated with nuclear extracts for 20 min on ice prior to binding reactions.
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uninfected cells (Fig. 5A, lanes 1–6). However, when Jurkat
cells were stimulated with PMA and ionomycin for 30 min
or 6 h, NF-nB complexes were detected (Fig. 5A, lanes 7–
9). The specificity of DNA–protein complex formation wasdetermined by competition studies with unlabeled compet-
itors. As expected, a 50-fold molar excess of bcoldQ CD40
NF-nB4 double-stranded oligonucleotide or a consensus
NF-nB site from the IL-2Ra promoter effectively competed
with the labeled probe and eliminated binding of nuclear
E.W. Harhaj et al. / Virology 333 (2005) 145–158152extracts from both C8166 and MT-2 cells (Fig. 5B, lanes 1,
2, 4, 5, 6, and 8). Although a GAS element overlaps this
NF-nB site, the IL-2Ra NF-nB site was able to compete
away the protein–DNA complex (Fig. 5B), suggesting that
only NF-nB proteins bind to the CD40 NF-nB4 DNA probe.
An unlabeled mutant CD40 NF-nB4 probe was unable to
compete with a labeled wild-type probe (Fig. 5B, lanes 1, 3,
5, and 7). The exact composition of the transcription factor
DNA–protein complexes in HTLV-I-infected cells and
activated Jurkat cells was ascertained by supershift analysis.
Supershift reactions performed using C8166 and MT-2
nuclear extracts revealed that p50 and c-Rel were the
predominant components of the NF-nB complexes (Fig.
5C). This observation was consistent with other studies
demonstrating that c-Rel, and not RelA, was the predom-
inant NF-nB trans-activating protein in HTLV-I-infected T
cells (Lanoix et al., 1994). We also observed that Tax
expression alone (Tax was expressed via a retroviral vector
in SUP-T1 cells) elicited binding to the proximal CD40
probe with p50 and c-Rel also being the predominant NF-
nB proteins (data not shown). Supershift analyses per-
formed with Jurkat cells indicated that RelA and p50 were
the major NF-nB factors induced after 6 h (Fig. 5C, lanes
13–18) and after a 30-min treatment with PMA and
ionomycin (data not shown). These results suggested that
HTLV-I infection resulted in binding of NF-nB dimers,
consisting of c-Rel and p50, to the proximal NF-nB element
(NF-nB4) of the CD40 promoter. Stimulation of Jurkat cells
with mitogens activated a distinct subset of NF-nB
complexes comprised primarily of RelA and p50.
CD40 engagement activates NF-jB in T cells
CD40 serves distinct roles in different cell types
including Ig isotype class switching in B cells and
maturation of DCs (van Kooten and Banchereau, 2000).
In multiple cell types, a major target of CD40 signaling is
NF-nB, which induces the expression of select target genes
to mediate effector function (Dadgostar et al., 2002).
However, it is not clear if the CD40 signaling pathway is
intact and functional in T lymphocytes. To address this
question, Jurkat T cells were infected with retroviral vectors
encoding CD40, GFP, or an empty vector. After 2 weeks of
G418 selection, the bulk population of infected cells was
subjected to flow cytometry to examine the expression of
cell surface CD40. Jurkat cells infected with CD40, but not
an empty vector or GFP (data not shown), exhibited
abundant cell surface CD40 expression (Fig. 6A). Jurkat-
GFP or Jurkat-CD40 cells were stimulated with recombinant
CD40L and activation of NF-nB was examined by InBa
degradation and EMSA. CD40L stimulation had no effect
on either InBa degradation or NF-nB DNA binding to a
consensus NF-nB site in Jurkat-GFP cells (Figs. 6B and C,
lanes 1–3). However, CD40L elicited both InBa degrada-
tion and NF-nB activation in Jurkat-CD40 cells (Figs. 6B
and C, lanes 4–6). To examine the functional significance ofCD40L stimulation of T cells, Jurkat-GFP or Jurkat-CD40
cells were transfected with an NF-nB reporter plasmid and
increasing amounts of a Tax expression vector, and either
treated with CD40L for 8 h or left untreated. Interestingly,
CD40 ligation strongly synergized with suboptimal levels of
Tax to activate NF-nB in Jurkat-CD40 but not Jurkat-GFP
cells (Fig. 6D, right panel). CD40L alone generally
activated NF-nB in Jurkat-CD40 cells by about 10–20-fold
and did not activate NF-nB in Jurkat-GFP cells (data not
shown). Together, these results indicated that CD40L
stimulation of T cells bearing the CD40 receptor leads to
functional activation of NF-nB.Discussion
In this study, we have demonstrated that (1) Tax
deregulates the expression of multiple TNF/TNFR genes,
including CD40; (2) CD40 mRNA and protein are
upregulated in HTLV-I-infected T cell lines; (3) the
HTLV-I Tax protein is sufficient to induce the expression
of CD40 in HTLV-I-negative T cells; (4) Tax requires the
NF-nB signaling pathway to activate CD40 gene expression
and also to activate the CD40 promoter; and (5) engagement
of CD40 on T cells by CD40L synergizes with suboptimal
levels of Tax to activate NF-nB.
This is the first report to demonstrate that CD40 gene
expression is regulated by Tax. There are several potential
functional effects of CD40 expression on T cells. CD40
engagement by CD40L leads to cellular activation, cytokine
production and Ig isotype class switching in B cells, and
maturation and cytokine production in DCs (Foy et al.,
1996; van Kooten and Banchereau, 2000). Previous studies
have suggested that CD40 expressed on T cells may
stimulate T cell activation and proliferation following
stimulation with recombinant CD40L (Armitage et al.,
1993). However, resting T cells typically express low to
undetectable levels of CD40, and activation of primary
peripheral blood T cells with mitogens did not result in a
significant induction of CD40, although CD40L was
strongly induced (data not shown). It has been demonstrated
that expression of CD40 on CD4+ T cells defines a highly
activated and pathogenic population of cells that may
mediate autoimmune disease (Wagner et al., 2002). Fur-
thermore, another report has suggested that CD40 expressed
on mouse CD8+ T cells may mediate CD4+ T cell help
through CD40L independent of APCs (Bourgeois et al.,
2002). Thus, under certain circumstances, CD40 expressed
on T cells may regulate T cell activation or effector function
upon encountering CD40L-expressing cells. Another poten-
tial effect of CD40 expression is down-regulation of CD40L
on HTLV-I-infected T cells from ATL patients. Binding of
CD40 on B cells by CD40L on T cells triggers receptor-
mediated endocytosis and degradation of CD40L, a mech-
anism ensuring transient expression of CD40L (Yellin et al.,
1994). This regulation has been exploited by multiple
Fig. 6. Ligation of CD40 on T cells mediates NF-nB activation. (A) Jurkat cells were infected with either an empty retroviral vector or a retroviral vector
encoding CD40. Infected cells were selected with G418 for 1 week, stained with either an anti-CD40-PE antibody or an isotype control, and subjected to flow
cytometry. CellQuest software was used for data analysis. (B) Jurkat cells expressing GFP (lanes 1–3) or CD40 (lanes 4–6) were either untreated (lanes 1 and 3)
or stimulated with human recombinant CD40L (2 Ag/ml) for either 30 min (lanes 2 and 5) or 6 h (lanes 3 and 6). Cytoplasmic proteins were resolved by SDS–
PAGE and Western blot analysis was performed with either anti-InBa antibody (top panel) or anti-a tubulin antibody (lower panel). (C) Jurkat cells expressing
GFP (lanes 1–3) or CD40 (lanes 4–6) were either untreated or stimulated with CD40L as described above. Nuclear extracts (4 Ag) were subjected to EMSA
with an NF-nB consensus probe. Non-specific DNA–protein complexes (ns). (D) Jurkat-GFP (1  106) and Jurkat-CD40 cells (1  106) were transfected with
an NF-nB reporter plasmid (nB-TATA Luc; 0.2 Ag) in the absence or presence of increasing amounts of a Tax expression vector (pCMV4-Tax) using FuGENE
6. Cells were either left untreated or treated with recombinant CD40L (2 Ag/ml) for 8 h prior to harvesting the extracts which were read with a luminometer.
The fold induction represents the fold difference of each sample relative to the untreated empty vector control. The experiment is representative of three
independent experiments.
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CD40L on activated T cells as a strategy to avoid immune
responses (Batrla et al., 2002). Indeed, it has been shown
that HTLV-I-infected T cells from ATL patients do not
express CD40L, an event that may contribute to immune
evasion and immune suppression (Makino et al., 2001). It is
possible that engagement of CD40 on HTLV-I-infected T
cells may also stimulate the down-regulation of CD40L on
activated T cells in an intra- or intercellular fashion. This
possibility is currently being explored with primary T cells
and also with JPX-9 cells, a Jurkat cell line that expresses
Tax in an inducible manner.
The NF-nB family of transcription factors plays an
important role in the regulation of CD40 expression. Murine
embryonic fibroblasts (MEFs) lacking RelA are defective in
the induction of CD40 following stimulation with LPS or
cytokines (Ouaaz et al., 1999). Furthermore, bone marrow-
derived DCs from RelB/ mice lack cell surface CD40
expression, and DCs generated from wild-type mice in the
presence of a chemical inhibitor of NF-nB nuclear trans-
location similarly lack CD40 expression (Martin et al.,
2003). Other studies have demonstrated the importance of
NF-nB in the regulation of CD40 expression by LPS (Tone
et al., 2002), IFNg (Nguyen and Benveniste, 2002), and in
Hodgkin/Reed-Sternberg cells (Hinz et al., 2001). However,
nothing is known regarding the regulation of CD40
expression in T cells. Our results suggest that NF-nB is
essential for Tax-mediated CD40 induction in T cells, and
the proximal NF-nB site (NF-nB4) appears to play an
important role.
Our results suggest that CD40 may participate in a
positive regulatory loop initiated by Tax in HTLV-I-infected
T cells. Tax upregulates the expression of CD40 and other
cell surface molecules which can then potentially synergize
with Tax to sustain an NF-nB response. A previous study
has indicated that overexpression of CD40 is sufficient to
activate NF-nB (Rothe et al., 1995). However, we did not
observe constitutive NF-nB activation in Jurkat cells stably
expressing CD40 (Fig. 6), thus interaction with CD40L may
be necessary for CD40-mediated NF-nB activation in T
cells. In addition, it is not certain if the NF-nB factors
induced by CD40 engagement are able to activate CD40
gene expression in T cells. Future studies will more
precisely examine the mechanisms and downstream events
mediated by CD40 signaling in T cells.
CD40 expression has been associated with a wide variety
of malignancies affecting hematopoietic cells such as B cell
lymphoma (Pham et al., 2002), cutaneous T cell lymphoma
(Storz et al., 2001), and Hodgkin/Reed-Sternberg cells
(Hinz et al., 2001). Curiously, CD40 expression is also
upregulated in nonhematopoietic neoplasms such as breast
(Hirano et al., 1999) and hepatocellular carcinoma (Sugi-
moto et al., 1999), squamous cell cancer of the head and
neck (Posner et al., 1999), as well as melanoma (von
Leoprechting et al., 1999). It has therefore been proposed
that CD40 may play a role in cell growth or survival andcontribute to the tumorigenic process. Although CD40
engagement on normal B cells leads to cell growth and
differentiation, engagement of CD40 on malignant CD40+
cells primarily induces growth arrest and apoptosis (Hess
and Engelmann, 1996; Hirano et al., 1999; Pham et al.,
2002). Thus, targeting tumors with agonistic CD40 anti-
bodies or soluble CD40L may prove to be of therapeutic
value. Indeed, results from a recent phase 1 clinical trial
suggest that recombinant CD40L administered to patients
with solid tumors or non-Hodgkin’s lymphoma displays
encouraging anti-tumor activity (Vonderheide et al., 2001).
It will be of interest to determine if CD40 engagement on
HTLV-I-infected T cells affects cell growth and viability.
Future studies will focus on additional molecular
mechanisms employed by Tax to activate CD40 gene
expression in T cells. Although NF-nB clearly plays an
important role in Tax-mediated induction of CD40, the
contribution of specific subunits needs to be more precisely
defined. Gene silencing of individual subunits by short
inhibitory RNAs (siRNA) will facilitate these studies. In
addition, the potential role of other transcription factors and
coactivators will be similarly examined. Pharmacologic
inhibition of NF-nB as well as other signaling pathways
may also be used to determine the role of other signaling
molecules targeted by Tax to activate CD40 gene expres-
sion. Understanding how Tax activates CD40 gene expres-
sion in T cells will elucidate strategies used by a retroviral
trans-activating protein to circumvent the normal regulation
of cell-type specific expression and silencing of genes.Materials and methods
Biological reagents and cell culture
The human T cell lymphocytic cell lines Jurkat and SUP-
T1, and the HTLV-I-transformed T cell lines C8166, MT-2,
SLB-1, and HUT-102, were cultured and maintained in
RPMI 1640 medium. The IKKg-deficient Jurkat cell line
(JM4.5.2) stably transfected with GFP (JM4.5.2-GFP) or
IKKg (JM4.5.2-IKKg) (Rivera-Walsh et al., 2000) was
cultured in RPMI medium containing G418 (1 mg/ml;
Invitrogen, Carlsbad, CA). Human embryonic kidney 293
cells were cultured in DMEM medium. All media for-
mulations were supplemented with 10% heat-inactivated
fetal bovine serum (FBS), penicillin (100 U/ml), strepto-
mycin (100 Ag/ml), l-glutamine (2 mM), and NaHCO3
(0.075%). Recombinant human CD40L (310-02) was
purchased from Peprotech Inc (Rocky Hill, NJ). The anti-
CD40-phycoerythrin (PE) (clone 5C3) and anti-mouse IgG
PE isotype control antibodies were purchased from BD
Pharmingen (San Diego, CA). The p50 (H-119), p52 (K-
27), a-tubulin (B-7), and rabbit control Ig antibodies were
obtained from Santa Cruz (Santa Cruz, CA). The p65
antibody (PC137) was obtained from Calbiochem (La Jolla,
CA). The c-Rel and InBa antibodies are peptide-specific
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(Harhaj et al., 2000).
Plasmid construction and transient expression analysis
The pCLXSN-GFP, pCLXSN-Tax, pCL-Ampho, VSV-G,
pCMV4-Tax, Tax M22, Tax M47, and NF-nB-TATA
luciferase constructs have been described previously (Harhaj
and Sun, 1999; Rivera-Walsh et al., 2001). pCLXSN-Tax
M22 and pCLXSN-Tax M47 were constructed by site-
directed mutagenesis using the QuikChange Site-Directed
Mutagenesis kit (Stratagene, La Jolla, CA). CD40 was
amplified by PCR from RSV-pCD40.neo (kindly provided
by Dr. Gail Bishop, University of Iowa, Iowa City, Iowa)
and cloned into the pCLXSN vector by Xho1 digestion
followed by ligation with T4 ligase (New England Biolabs,
Beverly, MA). The CD40 promoter (747 to 1 relative to
the translation start site) was amplified by PCR from Jurkat
genomic DNA, digested with XhoI and HindIII, and ligated
with pGL3. The CD40 promoter deletions were all similarly
generated by PCR and cloned into pGL3. All constructs
were confirmed by sequencing. The following primers were
used for cloning (restriction sites are underlined): (747,
XhoI) forward, 5V-TGCCTGCTCGAGCTCGGCCTCC-
TAAAGTGCTG; (544, XhoI) forward, 5V-TGCCTGCTC-
GAGGAGTTGGGAAACTCTTCCTTG; (427, XhoI)
forward, 5V-TGCCTGCTCGAGGTTCTGCCAGGATACC-
TAGAG; (327, XhoI) forward, 5V-TG CCTGCTC-
GAGGTCGCAGGAAGCAGGCTAG; (198, Xho I)
forward, 5V-TGCCTGCTCGAG GGAATTAGACTTG-
TGGGAATG; (56, XhoI) forward, 5V-TGCCTGCTC-
GAGGTCAGCAGAGGCCTCGCTC; (1, HindIII)
reverse, 5V-GCGCGCAAGCTTGGCGAGGTGAGAC-
CAGGC. The NF-nB4 binding site mutant, pGL3-
CD40(747) NF-nB4 mut, was mutated from GGGAAAC-
TCC to GGGAAACT by site-directed mutagenesis with
a QuikChange Site-Directed Mutagenesis Kit.
Transient transfections in Jurkat cells were performed
with the FuGENE 6 transfection reagent (Roche, Indian-
apolis, IN) following the manufacturer’s instructions.
Briefly, FuGENE 6 reagent was diluted with serum-free
Opti-MEM (Invitrogen), mixed with DNA samples, and
incubated at room temperature for 30 min. Cells were
harvested 36–48 h post-transfection and cell lysates were
prepared in 100 Al of 1 Passive Lysis Buffer (Promega,
Madison, WI). Luciferase activity was assayed using the
Luciferase Assay system according to the manufacturer’s
instructions (Promega, Madison, WI). Data in graphs
represent the average of at least three independent trans-
fections. Error bars indicate the standard error of the mean
(SEM) of at least three independent experiments.
Retroviral vector infections
Retroviral vector infections were performed essentially
as described (Naviaux et al., 1996; Rivera-Walsh et al.,2001). Indicated retroviral vector constructs (1 Ag of
either pCLXSN-GFP, Tax, or CD40) were cotransfected
with pCL-Ampho (1 Ag) and VSV-g (0.15 Ag) into 293
cells (3  105) in 6-well plates with FuGENE 6. After
48 h, viral supernatant was filtered through a 0.45 AM
polysulfone filter (Pall-Gelman Acrodisc; Fisher Scien-
tific, Pittsburgh, PA) and used to resuspend Jurkat or
SUP-T1 cells (1  106) into 6-well plates. Polybrene (8
Ag/ml; Sigma, St. Louis, MO) was added to each well,
and the cells were centrifuged at 1800 rpm for 45 min.
Cells were subsequently incubated at 37 8C, washed in
RPMI medium the following day, and expanded for 5–7
days in the presence of G418 (1 mg/ml).
Gene array
SUP-T1 cells (1  106) were infected with retroviruses
using filtered supernatant from 293 cells transfected with
either an empty vector (pCLXSN) or a Tax-encoding
retroviral vector (pCLXSN-Tax). One week post-infection,
total RNA was harvested using the Trizol reagent (Invi-
trogen). RNA was used for gene array analysis of TNF and
TNFR genes using the GEArray Original Series Human
TNF and TNFR Superfamily Gene Array kit (SuperArray,
Frederick, MD). The array contains 23 common TNF and
TNFR superfamily members and 2 housekeeping genes.
The protocol for the gene array was performed as described
by the manufacturer. Briefly, 5 Ag total RNA was converted
to cDNA in the presence of biotin-16-dUTP using the
AmpoLabeling-LPR kit (SuperArray). The gene array
membranes were hybridized with the cDNA probes over-
night at 68 8C. The membranes were washed, blocked,
incubated with AP-streptavidin, washed, rinsed with phos-
phatase reaction buffer, incubated with CDP-Star substrate,
and exposed to film. Individual spots on the arrays were
quantitated from the film using a Kodak Image Station 440.
Flow cytometry
The indicated cells (5  105) were incubated with 20 AL
of PE-conjugated anti-CD40 antibody or isotype control
antibody for 30 min in 100 Al of FACS buffer (PBS, 0.05%
NaN3, 3% FBS) on ice. Cells were washed once with ice-
cold FACS buffer, washed again with ice-cold PBS, and
resuspended in 300 Al of 2% paraformaldehyde. Fluores-
cence-activated flow cytometry was performed with a
FACScan 2000 (Becton Dickinson, Franklin Lakes, NJ)
flow cytometer. Live cells were gated based on forward- and
side-scatter properties. Single-color analyses were per-
formed with CellQuest software (BD Biosciences).
RT-PCR
Total RNA was isolated from cells with Trizol reagent
(Invitrogen) as recommended by the manufacturer. A total of
2 Ag of RNA was converted to cDNA in a reverse
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script; Qiagen, Valencia, CA). RT-PCR was performed to
amplify the indicated genes in a 50 Al reaction containing 2 Al
of cDNA, 1 PCR buffer (Invitrogen), 0.25 AM of forward
and reverse primers, 0.2 mM dNTP mix, 1.5 mMMgCl2, and
3 units of Platinum Taq polymerase (Invitrogen). PCR
products were resolved by agarose gel electrophoresis. The
following sets of primers were used to amplify gene products
for RT-PCR reactions: glyceraldehyde-3-phosphate dehydro-
genase (GAPDH) (263 bp) forward, 5V-CCACAGTCCATG-
CCATCAC, reverse 5V-GCTTCACCACCTTCTTGATG;
Tax (429 bp) forward, 5V-CGG ATACCCAGTCTACGTC,
reverse, 5V-GAGGTACATGCAGACAACGG; CD40 (833
bp) forward, 5V-CATGGTTCGTCTGCCTCTGC, reverse,
5V-CACTGTCTCTCCTGCACTGAG.
Western blotting
Western blotting was performed essentially as described
previously (Harhaj et al., 2000). Briefly, cytosolic and
nuclear extracts were harvested from the indicated cell type.
Cytosolic extracts (~20 Ag) were subjected to SDS–
polyacrylamide gel electrophoresis (PAGE) at 120 V for
2.5 h. Resolved proteins were transferred to nitrocellulose
membranes in transfer buffer at 120 mA for 2 h. Membranes
were blocked in 5% milk in phosphate-buffered saline
(PBS) with Tween 20 (0.2%, PBST), incubated with
primary antibodies for 1 h (anti-InBa 1:3000 dilution,
anti-a-tubulin 1:1000 dilution), washed three times with
PBST, incubated with mouse or rabbit Ig-horse radish
peroxidase (HRP)-conjugated antibodies (Amersham, Pis-
cataway, NJ), washed three times with PBST, and antigen–
antibody complexes were detected with Western Lightning
Enhanced Chemiluminescence (ECL) reagent (Perkin-
Elmer, Boston, MA).
Nuclear extract preparation and EMSA
Small-scale nuclear extracts were prepared from cells.
Briefly, cells (1  107) were centrifuged, washed in PBS,
and lysed in ice-cold buffer B (10 mM HEPES pH 7.9, 10
mM KCl, 0.1 mM EDTA, 0.4% IGEPAL, 1 mM dithio-
threitol [DTT], protease inhibitor cocktail (1:100), and 1
mM phenylmethylsulfonyl fluoride [PMSF]). The super-
natant was removed and transferred to new tubes after
centrifugation (14,000 rpm). The nuclear pellets were
washed once with buffer B, resuspended in buffer C (20
mM HEPES pH 7.9, 0.4 M NaCl, 1 mM EDTA, 1 mM DTT,
and 1 mM PMSF), shaken vigorously for 10 min at 4 8C,
and centrifuged for 5 min (14,000 rpm). The protein
concentration of each sample was determined by the DC
Protein Assay Kit (Biorad, Hercules, CA). The following
sequences were used to generate double-stranded oligonu-
cleotides for electrophoretic mobility shift assays (EMSA)
and competition experiments (the NF-nB sites are under-
lined and the mutations are boxed): CD40 NF-nB4 site:5V-GAATGTTCTGGGGAAACTCCTGCGCGG, CD40NF-
nB4 mutant site: 5V-GAATGTTCTG ATAAAACTC-
CTGCGCGG, IL-2Ra NF-nB site: 5V-CAACGGCAG
GGGAATCTCCCTCTCCTT. Radiolabeling of probes was
performed by a fill-in reaction with Klenow (Promega),
dNTPs, and [32P]a-dCTP. For EMSA, nuclear extract (4 Ag)
and radiolabeled probe (100,000 cpm) were incubated in
reaction buffer containing dialysis buffer (25 mM HEPES
pH 7.9, 10% glycerol, 100 mM KCl, 0.1 mM EDTA), poly
(dI-dC) (1 Ag), and DTT (1 mM) in a total reaction volume of
15 Al for 15 min at room temperature. The DNA–protein
complexes were resolved on a 5% polyacrylamide gel at
200V in 1 TBE buffer. The gels were dried under vacuum
at 80 8C for 1.5 h prior to autoradiography. Competition
EMSAs were performed by adding a 50-fold molar excess of
unlabeled homologous or heterologous oligonucleotides
with nuclear extract on ice for 20 min prior to binding
reactions. Supershifts were conducted by reacting the
indicated antibodies (1 Ag) with nuclear extracts on ice for
20 min prior to binding reactions.Acknowledgments
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